Response by Lundberg et al to Letter Regarding Article, "Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity From the Red Blood Cell"
- PMID: 31682526
- PMCID: PMC6834230
- DOI: 10.1161/CIRCULATIONAHA.119.043151
Response by Lundberg et al to Letter Regarding Article, "Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity From the Red Blood Cell"
Conflict of interest statement
Conflict of Interest Disclosures: JOL is a named co-inventor of patents and patent applications related to the medical uses of inorganic nitrate and nitrite. RPP and DBK-S are co-inventors on a patent for use of nitrite salts for the treatment of cardiovascular conditions
Comment on
-
Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity From the Red Blood Cell.Circulation. 2019 Jun 4;139(23):2654-2663. doi: 10.1161/CIRCULATIONAHA.118.039284. Epub 2019 Mar 25. Circulation. 2019. PMID: 30905171 Free PMC article.
References
-
- Sun C-W, Yang J, Kleschyov AL, Zhuge Z, Carlstrom M, Pernow J, Wajih N, Isbell TS, Oh J-Y, Cabrales P, Tsai AG, Townes T, Kim-Shapiro DB, Patel RP, Lundberg JO. Hemoglobin β93 cysteine is not required for export of nitric oxide bioactivity from the red blood Cell. Circulation. 2019;139:2654–2663. - PMC - PubMed
-
- Lundberg JO, Weitzberg E and Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008;7:156–67. - PubMed
-
- Guyton AC, Hall JE (1996) Overview of the circulation; Medical physics of pressure, flow, and resistance In: Guyton AC, Hall JE (eds) Textbook of Medical Physiology. W. B. Saunders Company, Philadelphia, pp 161–170.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources